Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, Corrado Campochiaro, Emanuel Della‐Torre, Giacomo De Luca, Nicola Farina, Nicola Boffini, Annalisa Ruggeri, Andrea Poli, Paolo Scarpellini, Patrizia Rovere‐Querini, Moreno Tresoldi, Andrea Salonia, Francesco Montorsi, Giovanni Landoni, Antonella Castagna, Fabio Ciceri, Alberto Zangrillo, Lorenzo Dagna
Topics & Concepts
MedicineAnakinraTocilizumabInternal medicineClinical endpointGastroenterologyClinical trialDiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders